Episode
Ep 72: Co-Founder of Chai Discovery Joshua Meier on 99% Faster Drug Discovery, BioTech’s AlphaGo Moment, Building Photoshop for Molecules
- Published
- Aug 13, 2025
- Duration seconds
- 3435
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/unsupervised-learning-with-jacob-effron-6041643/episodes/ep-72-co-founder-of-chai-discovery-joshua-meier-on-99-faster-drug-discovery-biotech-s-alphago-moment-building-photoshop-for-molecules/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/unsupervised-learning-with-jacob-effron-6041643/ep-72-co-founder-of-chai-discovery-joshua-meier-on-99-faster-drug-discovery-biotech-s-alphago-moment-building-photoshop-for-molecules.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Jacob sits down with Joshua Meier, co-founder of Chai Discovery and former Chief AI Officer at Absci, to explore the breakthrough moment happening in AI drug discovery. They discuss how the field has evolved through three distinct waves, with the current generation of companies finally achieving success rates that seemed impossible just years ago. The conversation covers everything from moving drug discovery out of the lab and into computers, to why AI models think differently than human chemists, to the strategic decisions around open sourcing foundational models while keeping design capabilities proprietary. It's an in-depth look at how AI is fundamentally changing pharmaceutical innovation and what it means for the future of medicine.